CBIO

Crescent Biopharma
CBIO

30 hedge funds and large institutions have $174M invested in Crescent Biopharma in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 20 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

less funds holding

Funds holding: →

25% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 20

Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$29.9M
2
+$29.4M
3
+$28.7M
4
BI
BVF Inc
California
+$27.3M
5
PBA
Paradigm Biocapital Advisors
New York
+$13.6M

Top Sellers

1
-$561K
2
-$120K
3
-$93.8K
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$80.3K
5
SC
Shay Capital
New York
-$74.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$22.8M
2
$22.4M
3
$22.4M
4
$22.4M
5
$10.4M
6
$8.94M
7
$7.32M
8
$7.32M
9
$7.32M
10
$7.32M
11
$7.32M
12
$6.46M
13
$4.88M
14
$4.52M
15
$4.22M
16
$2.9M
17
$1.63M
18
$1.22M
19
$809K
20
$437K
21
$248K
22
$149K
23
$97.7K
24
$4.62K
25
$3.6K
1
2